NYSE:BCAT BlackRock Capital Allocation Term Trust (BCAT) Stock Price, News & Analysis $13.43 +0.15 (+1.13%) Closing price 03:59 PM EasternExtended Trading$13.46 +0.03 (+0.22%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About BlackRock Capital Allocation Term Trust Stock (NYSE:BCAT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BCAT alerts:Sign Up Key Stats Today's Range$13.18▼$13.4550-Day Range$13.03▼$16.0752-Week Range$12.91▼$16.20Volume508,648 shsAverage Volume772,842 shsMarket Capitalization$1.42 billionP/E RatioN/ADividend Yield24.87%Price TargetN/AConsensus RatingN/A Company Overview BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a diversified, closed-end investment fund managed by BlackRock Advisors, LLC. The fund seeks to provide total return through a combination of current income and capital appreciation. BCAT invests across global equity and fixed-income markets, using a flexible asset-allocation strategy. Its portfolio may include common stocks, preferred securities, corporate and government bonds, mortgage- and asset-backed securities, convertible securities, and other income-producing investments. The fund may also use derivatives and other investment techniques to manage risk, enhance returns, or gain market exposure. As a term trust, BCAT is designed to operate for a defined period rather than indefinitely, subject to the terms described in its governing documents and any potential extensions or other actions approved in accordance with applicable requirements. The fund’s investments may span issuers and markets in the United States and other countries, giving shareholders exposure to a range of industries, asset classes, and geographies.AI Generated. May Contain Errors. Read More Receive BCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BlackRock Capital Allocation Term Trust and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCAT Stock News HeadlinesBlackRock Capital Allocation Term Trust (BCAT) Announces Results of its Rights OfferingOctober 21, 2026 | businesswire.comBlackRock Capital Allocation Trust's Dividend AnalysisOctober 15, 2026 | finance.yahoo.comWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.October 27 at 1:00 AM | Digest Publishing (Ad)BlackRock ESG Capital Allocation Trust's Dividend AnalysisOctober 15, 2026 | finance.yahoo.comCertain BlackRock Closed-End Funds Provide Updates on their Discount Management ProgramsOctober 1, 2026 | businesswire.comBCAT - BlackRock Capital Allocation TrustSeptember 20, 2026 | br.investing.comBlackRock Capital Allocation Term Trust (BCAT) Announces Terms of Rights Offering to Pursue Compelling Real Yields and Secular Growth Themes at an Attractive Entry PointSeptember 10, 2026 | businesswire.comBCAT: The Rally Masked A Structural FlawAugust 3, 2026 | seekingalpha.comSee More Headlines BCAT Stock Analysis - Frequently Asked Questions How have BCAT shares performed this year? BlackRock Capital Allocation Term Trust's stock was trading at $14.18 at the beginning of the year. Since then, BCAT shares have decreased by 5.3% and is now trading at $13.43. When did BlackRock Capital Allocation Term Trust IPO? BlackRock Capital Allocation Term Trust (BCAT) raised $2 billion in an initial public offering on Friday, September 25th 2020. The company issued 100,000,000 shares at $20.00 per share. Who are BlackRock Capital Allocation Term Trust's major shareholders? BlackRock Capital Allocation Term Trust's top institutional investors include CoreCap Advisors LLC (0.06%), Winebrenner Capital Management LLC (0.06%), Triumph Capital Management (0.04%) and Valen Private Capital LLC (0.04%). Insiders that own company stock include Saba Capital Management, LP and Stayce D Harris. View institutional ownership trends. How do I buy shares of BlackRock Capital Allocation Term Trust? Shares of BCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BlackRock Capital Allocation Term Trust own? Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Capital Allocation Term Trust investors own include AGNC Investment (AGNC), NVIDIA (NVDA), Oxford Lane Capital (OXLC), Dynex Capital (DX), PIMCO Dynamic Income Fund (PDI), Eagle Point Credit (ECC) and Pfizer (PFE). Company Calendar Today10/27/2026Record date for 11/30 Dividend11/13/2026Ex-Dividend for 11/30 Dividend11/13/2026Dividend Payable11/30/2026Record date for 12/22 Dividend12/11/2026Ex-Dividend for 12/22 Dividend12/11/2026Dividend Payable12/22/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 BCAT's financial health is in the Red zone, according to TradeSmith. BCAT has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Capital Markets Sub-IndustryN/A Current SymbolNYSE:BCAT CIK1809541 Webwww.blackrock.com Phone212-810-5300FaxN/AEmployees147,000Year Founded1988Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$252.81 million Price / Sales5.60 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares105,414,000Free FloatN/AMarket Cap$1.42 billion OptionableNot Optionable Beta0.79 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:BCAT) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, a Chevron drilling team tapped an energy source powerful enough to run a city, then buried the projec...Behind the Markets | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BlackRock Capital Allocation Term Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share BlackRock Capital Allocation Term Trust With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
